Already approved for smoking and treatment-resistant depression, brain stimulation is being tested for multiple addictions ...

Psilocybin-assisted psychotherapy (PAP) has been shown to potentially have mental health benefits for patients with cancer, ...

Mental health professionals have made great advancements in the therapeutic use of psychedelic drugs in recent years.

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing in natural psilocybin and MDMA, ...

As Colorado becomes the second state to legalize psychedelic therapy this week, a clash is playing out in ... While research ...

Former television and film star Eliza Dushku, best known for her role as Faith in “Buffy the Vampire Slayer,” has revealed a ...

In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug ...

MDMA-assisted therapy for post-traumatic stress disorder. This decision comes just months after advisors to the agency voted against evidence supporting MDMA therapy . The agency's decision was ...

MDMA, psilocybin, ketamine derivatives, and other hallucinogens are authorised in certain countries to treat depression or ...

As New Year’s Eve rolls around, clubbers engaging in a little extra-curricular activity (aka taking copious amounts of drugs) are more at risk than usual this year, according to sources who have ...

announces that Health Canada has approved the Company's Clinical Trial Application to examine the feasibility of a group model in MDMA-assisted psychotherapy enrolling trainee practitioners as ...

Hopeful therapists and their patients were dejected after Lykos Therapeutics’ application for MDMA-assisted therapy was rejected as a treatment for post-traumatic stress disorder (PTSD) by the Food ...